By Elric Langton | 15th December 2021
OptiBiotix Health plcย (AIM: OPTI), a life sciences ingredients business developing unique science and human study-based compounds designed to address diabetes, low-grade systemic inflammation, obesity, cardiovascular disease, high cholesterol, and to support healthy ageing,ย has signed an exclusive supply agreement wiโฆ